LABU Long analysis on the monthly. Looks like a lot of accumulation looking to breakout biggins.
LABU is showing really good support. It's currently in a decline but should hold at $48.95 ish with a bounce and possible triangular breakout.
Moving average convergence/divergence crossover on multiple timeframes, RSI rising quickly out of overbought area, price bounced off of a long term price support/resistance line. Target $70 : Tight stop loss
LABD is finally perking up. Buying it as a hedge. chart starting to look good
These are the top yielding securities in the equities market: NASDAQ:AAPL SOXL TSLA AMEX:FNGU NASDAQ:TQQQ NASDAQ:AMZN and AMEX:LABU . All of the exchange-traded funds are 3x leveraged (make sure that you understand how these work) and have the potential to be volatile. Also, Tesla and Amazon may be in a bubble.
Remdesivr, monoclonal antibodies
Buying LABU here, might be a little early. The price is above the 10 sma although many of the supporting averages are not aligned higher. Its more gambling than investing at this point.
As long as my line stay green adding on dip this week is an opportunity to profit early in Spring ( seeded time for #biotech is now) but mostly trading on daily base , today I wait longer 3-4 days perhaps
EYPT chart is building up for another run. Potential catalyst before year end with an sNDA for Short Duration Yutiq. accumulation has been slow and steady indicating EYPT oversold conditions. Technical's: weekly chart --> Harmonic Gartley (bounced off significant support level) and been in uptrend since. Symmetrical Triangle/ Breakout setup has been known...
Biotech buyouts have been very strong, especially with Gene therapy stocks as of late. Bounced off Lower end of channel Gartley pattern bounced off 1.618 fib extension along with important reversal leg of Elliott Wave Theory. if price holds inside the lower end of the channel there is a potential move back up and test the gap. looking for nice $0.40+ swing...
WIth Warren and Bernie fading a bit, Bio/health have jumped nicely. Too much too soon IMO, at the minimum a short term pull back is coming. I am hoping we can become more range bound in the technicals and return to cyclical trading between 78 and 87, this type of cycle is great IBB and XBI, however getting caught when it breaks down can hurt! I use XBI has my...
LABU is currently in a descending channel and I don"t believe we will be breaking said channel look for a bounce of the top it is currently very overbought. PT1=24.75 PT2=Bottom of channel SL=36.00
As the month of October begins and broader markets sold off, Biotech sectors are still negative/ flat for the year. Market headlines from high prescription drug prices and lawsuits regarding the opioid epidemic have plagued some of the IBB's largest holdings; which have held biotech ETF's down while the S&P reached all time highs. Fast-Track Synopsis: ...